Target
etoposides
2 abstracts
Abstract
Apatinib combined with ifosfamide and etoposide versus ifosfamide and etoposide in relapsed or refractory osteosarcoma (OAIE/PKUPH-sarcoma 11): A multicenter, randomized controlled trial.Org: Jiangsu Hengrui Pharmaceuticals Co, Ltd., Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University,
Abstract
Efficacy and safety of pembrolizumab (pembro) in children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) with slow early response (SER) to front-line chemotherapy (chemo) in the phase 2, open-label, KEYNOTE-667 study.Org: IRCCS Ospedale Pediatrico Bambino Gesu, University College London Hospitals NHS Foundation Trust, Hospital Universitari Vall d Hebron, Regina Margherita Childrens Hospital and University of Turin, Turin, Italy, Princess Máxima Centrum,